Alpha-Synuclein Neuronal Uptake

Alpha-Synuclein Neuronal Uptake

Overview

The uptake of extracellular alpha-synuclein by neurons is a critical step in the prion-like propagation of pathology in Parkinson's disease. Multiple uptake mechanisms have been identified, including endocytosis, macropinocytosis, and receptor-mediated uptake. Understanding these pathways is essential for developing therapies that can block the spread of pathology and for interpreting biomarker data from cerebrospinal fluid and blood.

Uptake Mechanisms

Receptor-Mediated Endocytosis

Several receptors have been implicated in alpha-synuclein uptake:

Alpha-Synuclein Neuronal Uptake

Overview

The uptake of extracellular alpha-synuclein by neurons is a critical step in the prion-like propagation of pathology in Parkinson's disease. Multiple uptake mechanisms have been identified, including endocytosis, macropinocytosis, and receptor-mediated uptake. Understanding these pathways is essential for developing therapies that can block the spread of pathology and for interpreting biomarker data from cerebrospinal fluid and blood.

Uptake Mechanisms

Receptor-Mediated Endocytosis

Several receptors have been implicated in alpha-synuclein uptake:

Lymphocyte-Activation Gene 3 (LAG3): LAG3 was identified as a specific receptor for alpha-synuclein aggregates [@mao2016](https://pubmed.ncbi.nlm.nih.gov/27708076/). LAG3 preferentially binds oligomeric and fibrillar forms of alpha-synuclein, enabling selective uptake of pathological species:

• High-affinity binding to alpha-synuclein aggregates
• Internalization via clathrin-dependent mechanisms
• Blocking LAG3 reduces uptake and propagation in cellular models
• LAG3 is expressed in neurons, particularly in the substantia nigra

• Toll-Like Receptors (TLR2, TLR4): May recognize alpha-synuclein as a damage-associated molecular pattern
• Prion Protein (PrP): Some evidence for interaction with alpha-synuclein
• Cell Adhesion Molecules: May facilitate uptake at synapses

Clathrin-Dependent Endocytosis

Classical clathrin-mediated endocytosis represents a major pathway for alpha-synuclein uptake:

Dynamin inhibition significantly reduces alpha-synuclein uptake, confirming the role of this pathway [@barman2021](https://pubmed.ncbi.nlm.nih.gov/34056823/).

Caveolin-Dependent Endocytosis

Caveolae represent an alternative entry point:

• Caveolae Structure: Flavin-containing flask-shaped invaginations
• Role in Neuronal Uptake: May contribute to uptake in specific neuronal populations
• Cargo Specificity: May preferentially internalize certain alpha-synuclein species

Macropinocytosis

Large-scale fluid-phase uptake can also mediate alpha-synuclein entry:

Activation: Growth factors, cellular stress, and certain proteins trigger macropinocytosis

Process: Membrane ruffling and closure forms large vesicles (0.2-5 μm) called macropinosomes

Uptake: Nonselective capture of extracellular fluid and any solutes present

Inflammatory signals may promote macropinocytic uptake of alpha-synuclein, particularly in microglia and infiltrating immune cells [@despotes2022](https://pubmed.ncbi.nlm.nih.gov/36218561/).

Direct Membrane Permeabilization

Alpha-synuclein oligomers can directly permeabilize membranes:

• Pore Formation: Oligomeric species form ion channels in the plasma membrane
• Channel-Mediated Entry: May allow direct passage of monomers into the cytoplasm
• Subunit Exchange: May enable direct transfer of alpha-synuclein between cells at points of contact

Cell-Type Specific Uptake

Neuronal Uptake

Neurons are the primary targets for pathological alpha-synuclein uptake:

Substantia Nigra Dopaminergic Neurons: High susceptibility to uptake and subsequent pathology:

• High expression of LAG3
• Extensive axonal arborization increasing exposure
• Metabolic vulnerability amplifies toxicity

• Lower basal uptake rates
• Different receptor expression patterns

Glial Uptake

Glial cells also take up alpha-synuclein:

Microglia: Professional phagocytes that clear extracellular alpha-synuclein:

• High uptake capacity through phagocytosis and endocytosis
• May spread pathology to other cells
• Inflammatory activation affects uptake kinetics

• Potential for trans-astrocytic transport
• May contribute to propagation via end-feet

Intracellular Trafficking

Endosomal Processing

After internalization, alpha-synuclein follows the endocytic pathway:

Endosomal Escape

For templated conversion to occur, alpha-synuclein must escape the endosome:

• Endosomal Membrane Permeabilization: Caused by oligomeric alpha-synuclein
• pH-Dependent Release: Acidic endosomal pH may promote release
• ESCRT-Mediated Trafficking: May deliver seeds to the cytoplasm

Implications for Templated Conversion

The endosomal compartment may serve as a protected environment for templated conversion:

• Endosomal membranes may catalyze conformational changes
• Local concentration of endogenous alpha-synuclein in endosomes
• Spatial separation from cytoplasmic quality control systems

Factors Affecting Uptake

Alpha-Synuclein Properties

Oligomeric State: Oligomers and fibrils are taken up more efficiently than monomers:

• Higher affinity for receptors
• More potent activators of macropinocytosis

• Phosphorylation (pS129) enhances uptake
• Nitration increases binding to receptors

Cellular Properties

Receptor Expression: LAG3 and other receptor levels determine uptake capacity

Endocytic Capacity: Activity of clathrin-mediated and other pathways

Cellular Stress: Stress conditions may increase uptake through multiple mechanisms

Therapeutic Implications

Blocking Uptake

Inhibiting neuronal uptake could halt pathology propagation:

• LAG3 Antagonists: Antibodies or small molecules blocking LAG3
• Receptor Downregulation: Reducing surface receptor expression
• Dynamin Inhibitors: Blocking clathrin-mediated endocytosis (caution: effects on normal endocytosis)

Modulating Endocytic Pathways

Targeting downstream trafficking:

• Endosomal Acidification: Inhibiting endosomal maturation
• ESCRT Modulation: Affecting endosomal sorting

Antibody-Mediated Blocking

Immunotherapy approaches to block uptake:

• Antibody Binding: Antibodies bound to extracellular alpha-synuclein may prevent receptor interactions
• Fc Receptor Effects: Antibody-opsonized alpha-synuclein may be differentially cleared [@holmes2023](https://pubmed.ncbi.nlm.nih.gov/37279476/)

Biomarker Implications

CSF Uptake Markers

Understanding uptake informs biomarker interpretation:

• Free alpha-synuclein in CSF may represent different pools than exosome-associated
• Seeding activity reflects uptake-competent species in the CSF

Blood-Brain Barrier Considerations

Peripheral and CNS compartments interact:

• Blood-derived alpha-synuclein may enter the CNS through uptake mechanisms
• Peripheral uptake into neurons is limited by the blood-brain barrier

See Also

• [Synuclein Pathway in Parkinson's Disease](/mechanisms/synuclein-pathway-parkinsons)
• [Alpha-Synuclein Prion-Like Spreading](/mechanisms/alpha-synuclein-prion-like-spreading)
• [Alpha-Synuclein Seeding Kinetics](/mechanisms/alpha-synuclein-seeding-kinetics)
• [Alpha-Synuclein Exosomal Secretion](/mechanisms/alpha-synuclein-exosomal-secretion)
• [Tunneling Nanotubes for Alpha-Synuclein Transfer](/mechanisms/tunneling-nanotubes)

References